Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q9H227
UPID:
GBA3_HUMAN
Alternative names:
Cytosolic beta-glucosidase-like protein 1; Cytosolic galactosylceramidase; Cytosolic glucosylceramidase; Cytosolic glycosylceramidase; Glucosidase beta acid 3; Glucosylceramidase beta 3; Klotho-related protein
Alternative UPACC:
Q9H227; Q32LY7; Q3MIH4; Q53GG8; Q6NSF4; Q8NHT8; Q9H3T4; Q9H4C6
Background:
Cytosolic beta-glucosidase, known by alternative names such as Cytosolic beta-glucosidase-like protein 1 and Glucosylceramidase beta 3, plays a pivotal role in the catabolism of glycosylceramides. It exhibits a broad substrate specificity, hydrolyzing galactosylceramides, glucosylsphingosines, and more. This enzyme also shows significant activity towards a variety of dietary glycosides, including phytoestrogens and flavonoids, suggesting a role in xenobiotic metabolism.
Therapeutic significance:
Understanding the role of Cytosolic beta-glucosidase could open doors to potential therapeutic strategies.